Targeting threat sensitivity in people with both anxiety and depression

Processes and circuitry underlying threat sensitivity as a treatment target for comorbid anxiety and depression

NIH-funded research Laureate Institute for Brain Research · NIH-11251325

Researchers are testing whether being extra-sensitive to threat explains symptoms in people who have both major depression and an anxiety disorder.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLaureate Institute for Brain Research NIH-funded
Lab location1 site (Tulsa, United States)
Project IDNIH-11251325 on NIH RePORTER

What this research studies

If you take part, researchers will compare people with both depression and anxiety to those with only depression or only anxiety using questionnaires, behavioral tasks, startle muscle recordings, and brain scans (fMRI). The project looks at two kinds of threat responses — potential threat (anxiety) and acute threat (fear) — to see which circuits drive symptoms. The team will combine self-report, physiological, and neural measures to pinpoint circuit-level differences that relate to symptom severity. Results would be used to develop objective measures and possible treatment targets for people with these comorbid conditions.

Who could benefit from this research

Good fit: Adults diagnosed with major depressive disorder plus at least one anxiety disorder who can complete questionnaires, behavioral tests, and MRI scans are ideal candidates.

Not a fit: People who have only depression or only an anxiety disorder, or who cannot undergo MRI or startle/physiological testing, are unlikely to benefit directly from this project.

Why it matters

Potential benefit: Findings could lead to better ways to measure symptom severity and new treatment targets for people with both anxiety and depression.

How similar studies have performed: Prior pilot data and related work link threat sensitivity to anxiety, but applying these measures specifically to comorbid anxiety-plus-depression is a newer, partly tested approach.

Where this research is happening

Tulsa, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.